Human T-cell lymphoblastic lymphoma expressing the T-cell receptor γ/δ established in immune-deficient (bg/nu/xid) mice

Leukemia

Volumn 7, Issue 2, 1993, Pages 281-289

  Biondi, Andrea ^a,e   Motta, Teresio ^d   Garofalo, Angela ^c   Rossi, Vincenzo ^a   Giudici, Giovanni ^a   Rizzo, Virginia ^a   Pioltelli, Pietro ^b   Corneo, Gianmarco ^b   Barbui, Tiziano ^d   Parma, Alberto ^d   Rambaldi, Alessandro ^c,d   Giavazzi, Raffaella ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b H S Gerardo   (Italy)

^c MARIO NEGRI INST PHARMACOL RES   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e Clin Pediat Univ Milano Bicocca   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE; T LYMPHOCYTE RECEPTOR;

ABDOMINAL DISTENSION; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CANCER INVASION; CANCER TRANSPLANTATION; CENTRAL NERVOUS SYSTEM METASTASIS; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; KARYOTYPE; KIDNEY; LIVER; LYMPHADENOPATHY; LYMPHOBLASTOMA; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLENOMEGALY; T CELL LYMPHOMA; TUMOR GROWTH;

ADOLESCENT; ANIMAL; BLOTTING, SOUTHERN; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMAN; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, T-CELL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PHENOTYPE; SPECIFIC PATHOGEN-FREE ORGANISMS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0027462798     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Watanabe S, Shimosato Y, Kameya T, Kuroki M, Kitahara T, Minato K, Shimoyama M. Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa Strain) in nude mice conditioned with whole-body irradiation. Cancer Res 1978;38:3494-3498.
2. Witte DP, Harris RE, Jenski JL, Lampkin BC. Megakaryoblastic leukemia in an infant. Establishment of a megakaryocytic tumor cell line in athymic nude mice. Cancer 1986;58:238-244.
3. Nara N, Miyamoto T. Direct and serial transplantation of human acute myeloid leukaemia into nude mice. Br J Cancer 1982;45:778-782.
4. Ueyama Y, Morita K, Kondo Y, Sato N, Asano S, Ohsawa N, Sakurai M, Nagumo F, lijima K, Tamaoki N. Direct and serial transplantation of a Ph-positive human myeloblastoid tumour into nude mice. Br J Cancer 1977; 36:523-527.
5. Arione R, Jemma C, Forni M, Marchese, Q, Benetton G, Giubellino C, Modesti A, Martinotti MG, Montezemolo LC, Musso T, Forni G. A new childhood T-cell lymphoma established in nude mice and in vitro. Cancer Res 1988; 48:1312-1318.
6. Lozzio BB, Machado EA. Transplantation and dissemination of human hematopoietic malignant cells in nude and Lasat mice. In: J. Fogh and B.C. Giovanella, eds. The nude mouse in experimental and clinical research. New York: Academic Press, 1982, pp 521-567.
7. Epstein AL, Herman MM, Kim H, Path RFD, Kaplan HS. Biology of the human malignant lymphomas III. Intracranial heterotransplantation in the nude, athymic mouse. Cancer 1976;37:2158-2176.
8. Schaadt M, Kirchner H, Fonatsch C, Diehl V. Intracranial heterotransplantation of human hematopoietic cells in nude mice. Int J Cancer 1979;23:751-761.
9. White L, Trickeft A, Norris MD, Tobias V, Sosula L, Marshall GM, Stewart BW. Heterotransplantation of human lymphoid neoplasms using a nude mouse intraocular xenograft model. Cancer Res 1990;50: 3078-3086.
10. Martinotti MG, Arione R, Foà R, Pegoraro L, Jemma C, Forni G. Serial transplantation of a human acute T lymphoblastic leukemia into nude mice. Tumori 1986; 72:553-558.
11. Igarashi T, Oka K, Miyamoto T. Human non-Hodgkin's malignant lymphomas serially transplanted in nude mice conditioned with whole-body irradiation. J Cancer 1989; 59:356-360.
12. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527-530.
13. Andriole GL, Mulé JJ, Hansen CT, Linehan WM, Rosenberg SA. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice. J Immunol 1985;135:2911-2913.
14. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335: 256-259.
15. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-1639.
16. Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988; 242:1706-1709.
17. Dick JE. Immune-deficient mice as models of normal and leukemic human hematopoiesis. Cancer Cells 1991; 3:39-48.
18. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989;246: 1597-1600.
19. Cesano A, O'Connor R, Lange B, Finan J, Rovera G, Santoli D. Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 1991;77:2463-2474.
20. Waller EK, Kamel OW, Cleary ML, Majumdar AS, Schick MR, Lieberman M, Weissman IL. Growth of primary T-cell non-Hodgkin's lymphoma in SCID-hu mice-requirement for a human lymphoid microenvironment. Blood 1991;78:2650-2665.
21. Kamel-Reid S, Letarte M, Doedens M, Greaves A, Murdoch B, Grunberger T, Lapidot T, Thorner P, Freedman MH, Phillips RA, Dick JE. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in SCID mice. Blood 1991;78:2973-2981.
22. Jansen B, Uckun FM, Jaszcz WB, Kersey JH. Establishment of a human t(4;11) leukemia in severe combined immunodeficient mice and successful treatment using anti-CD19 (B43)-pokeweed antiviral protein immunotoxin. Cancer Res 1992;52:406-412.
23. Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens M, Grunberger T, Thorner P, Freedman MH, Phillips RA, Letarte M. Differential kinetics of engrafment and induction of CDIO on human pre-B leukemia cell lines in immune deficient. Leukemia 1992;6:8-17.
24. Nathwani BN, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer 1976;38:964-983.
25. Grogan T, Spier C, Wirt DP, Hicks MJ, Paquin M, Hutter J, Miller T, Rangel C, Richter L, Jones S. Immunologic complexity of lymphoblastic lymphoma. Diagnostic Immunol 1986;4:81-88.
26. Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA: Lymphoblastic lymphoma: An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 1986;67:474-478.
27. Picker LJ, Weiss LM, Medeiros LJ, Good GS, Warnke RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987;128: 181-201.
28. Falini B, Flenghi L, Fagioli M, Martelli MF, Pileri S, Grignani F, Beltrami A, Novero D, Pelicci PG. T-lymphoblastic lymphomas expressing the non-disulfide-linked form of the T-cell receptor γ/δ: Characterization with monoclonal antibodies and genotypic analysis. Blood 1989;74:2501-2507.
29. Gouttefangeas C, Bensussan A, Boumsell L. Study of the CDS-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemia. Blood 1990;75:931-934.
30. Parcel JP, Gaulard P, Marolleau JP, Le Couedic JP, Hanni T, Gourdin MF, Divine M, Haioun C, Zafrani S, Goossens M, Hercend T, Reyes F. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γ/δ Blood 1990;75: 2213-2219.
31. National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's Lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135.
32. Cordell J, Falini B, Erber WN, Ghosh A, Abdulaziz Z, MacDonald S, Pulford K, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phoshphatase and monoclonal anti-phoshphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-229.
33. Lanier LL, Ruitenberg JJ, Allison JP, Weiss A. Biochemical and flow cytometric analysis of CD3 and Ti expression on normal and malignant T cells. In: AJ. McMichael, ed. Leukocyte typing III. New York: Oxford University Press, 1987, pp 175-178.
34. Biondi A, Di Celle PF, Rossi V, Casorati G, Matullo G, Giudici G, Foa R, Migone N. High prevalence of T-Cell receptor Vδ2-(D)-Dδ3 or Dδ1/2-Dδ3 rearrangements in B-precursor acute lymphoblastic leukemias. Blood 1990; 75:1834-1840.
35. Hara J, Benedict SH, Champagne E, Takihara Y, Mak TW, Minden M, Gelfand EW. T-cell receptor δ gene rearrangements in acute lymphoblastic Leukemia. J Clin Invest 1988;82:1974-1982.
36. Takihara Y, Reiman J, Michalopoulos E, Ciccone E, Moretta L, Mak TW. Diversity and structure of human T-cell receptor δ chain gene in peripheral blood γ/δ-bearing T-Iymphocytes. J Exp Med 1989;169:393-405.
37. Lefranc MP, Forster A, Rabbitts TH. Two distinct T cell δ variable region genes rearranged in human DNA. Nature 1984;312:521-524.
38. Feinberg AP, Vogelstein B. A Technique for radio-labelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;1132:6-9.
39. Fogh J, Bean MA, Bruggen J, Fogh H, Fogh JM, Hammar SP, Kodera Y, Loveless JD, Sorg C, Wright WC. Comparison of a human tumor cell line before and after growth in the nude mouse. In: J Fogh, BC Giovanella, eds. The nude mouse in experimental and clinical research. New York: Academic Press, 1978, pp 215-234.
40. Giovanella BC, Fogh J. The nude mouse in cancer research. Adv Cancer Res 1985;44:69-120.
41. Giavazzi R, Campbel DE, Jessup JM, Cleary K, Fidler IJ. Metastatic behaviour of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites of nude mice. Cancer Res 1986;46: 1928-1933.
42. Giavazzi R. Metastatic models. In: E Boven and B, Winograd, eds. The nude mouse in oncology research. Boca Raton: CRC Press, 1991, pp 117-132.